Cell Growth & Differentiation, Vol 4, Issue 11 947-954, Copyright © 1993 by American Association of Cancer Research

ARTICLES

The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules

R Costello, C Cerdan, C Lipcey, M Algarte, Y Martin, PA Baeuerle, D Olive and J Imbert
Unite 119, Institut National de la Sante et de la Recherche Medicale, Marseille, France.

Stimulation of primary human T-lymphocytes via CD2 and CD28 adhesion molecules induces a long-lasting proliferation (> 3 weeks). This potent activation does not require accessory cells, such as monocytes, but depends on persistent interleukin 2 (IL-2) secretion and receptivity, which is associated with high and prolonged expression of the inducible CD25/IL-2 receptor alpha (IL-2R alpha) chain gene. The transcription factor NF-kappa B participates in the regulation of both IL-2 and IL-2R alpha genes, as well as multiple cellular genes involved in T-cell proliferation. To evaluate the role of NF-kappa B in human peripheral blood T-lymphocytes, we previously analyzed the activation of NF-kappa B-related complexes in response to CD2+CD28 costimulation. We demonstrated a long-term induction of p50/p65 heterodimer, a putative p65/c-Rel heterodimer, and a constitutive nuclear expression of KBF1/p50 homodimers. As the role of p50 remains unclear, we focused our present study on NF-kappa B1 (p50/p105) gene regulation. Using electrophoretic mobility shift assays and Western and Northern blot analyses, we studied NF-kappa B1 gene expression during T-cell stimulation via CD2+CD28. We observed a transient 4- to 5-fold increase of NF-kappa B1 gene expression at both the mRNA and protein levels, lasting for at least 24 h. p50 DNA-binding activity apparently stays highly controlled when p105 expression is enhanced by a physiological stimulus of peripheral blood T-cells. Partial inhibition of p50 and p105 expression by NF-kappa B1 antisense oligonucleotides significantly reduced T-cell proliferation and CD25/IL-2R alpha cell surface expression.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. V. Podgoreanu, G. A. Michelotti, Y. Sato, M. P. Smith, S. Lin, R. W. Morris, H. P. Grocott, J. P. Mathew, and D. A. Schwinn Differential cardiac gene expression during cardiopulmonary bypass: Ischemia-independent upregulation of proinflammatory genes J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 330 - 339. [Abstract] [Full Text] [PDF]

				F. D'Acquisto, M. J. May, and S. Ghosh Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies Mol. Interv., February 1, 2002; 2(1): 22 - 35. [Abstract] [Full Text] [PDF]

				J. Fan, R. D. Ye, and A. B. Malik Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1037 - L1050. [Abstract] [Full Text] [PDF]

				X. Wang, H. Luo, H. Chen, W. Duguid, and J. Wu Role of Proteasomes in T Cell Activation and Proliferation J. Immunol., January 15, 1998; 160(2): 788 - 801. [Abstract] [Full Text] [PDF]

				B. Kahn-Perles, C. Lipcey, P. Lecine, D. Olive, and J. Imbert Temporal and Subunit-specific Modulations of the Rel/NF-kappa B Transcription Factors Through CD28 Costimulation J. Biol. Chem., August 29, 1997; 272(35): 21774 - 21783. [Abstract] [Full Text] [PDF]

				P. C. Cogswell, M. W. Mayo, and A. S. Baldwin Jr. Involvement of Egr-1/RelA Synergy in Distinguishing T Cell Activation from Tumor Necrosis Factor-alpha -induced NF-kappa B1 Transcription J. Exp. Med., February 3, 1997; 185(3): 491 - 498. [Abstract] [Full Text] [PDF]